| Product Code: ETC7362998 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Grenada`s import of adalimumab saw a shift in concentration from high to moderate, indicating a more diversified source of shipments. The top exporting countries to Grenada include Saint Lucia, Barbados, Ireland, USA, and Trinidad and Tobago. Despite a negative compound annual growth rate (CAGR) from 2020 to 2024, there was a positive growth rate in 2024, showcasing a potential turnaround in the market. This data suggests a burgeoning market for adalimumab imports in Grenada with a promising outlook for future growth and development.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Grenada Adalimumab Market Overview |
3.1 Grenada Country Macro Economic Indicators |
3.2 Grenada Adalimumab Market Revenues & Volume, 2021 & 2031F |
3.3 Grenada Adalimumab Market - Industry Life Cycle |
3.4 Grenada Adalimumab Market - Porter's Five Forces |
3.5 Grenada Adalimumab Market Revenues & Volume Share, By Drug class, 2021 & 2031F |
3.6 Grenada Adalimumab Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.7 Grenada Adalimumab Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.8 Grenada Adalimumab Market Revenues & Volume Share, By Dosage Strength, 2021 & 2031F |
3.9 Grenada Adalimumab Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.10 Grenada Adalimumab Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.11 Grenada Adalimumab Market Revenues & Volume Share, By Dosage Form, 2021 & 2031F |
4 Grenada Adalimumab Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Grenada Adalimumab Market Trends |
6 Grenada Adalimumab Market, By Types |
6.1 Grenada Adalimumab Market, By Drug class |
6.1.1 Overview and Analysis |
6.1.2 Grenada Adalimumab Market Revenues & Volume, By Drug class, 2021- 2031F |
6.1.3 Grenada Adalimumab Market Revenues & Volume, By Antirheumatics, 2021- 2031F |
6.1.4 Grenada Adalimumab Market Revenues & Volume, By TNF Alfa Inhibitors, 2021- 2031F |
6.1.5 Grenada Adalimumab Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Grenada Adalimumab Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 Grenada Adalimumab Market Revenues & Volume, By Rheumatoid Arthritis, 2021- 2031F |
6.2.3 Grenada Adalimumab Market Revenues & Volume, By Ankylosing Spondylitis, 2021- 2031F |
6.2.4 Grenada Adalimumab Market Revenues & Volume, By Chronic Plaque Psoriasis, 2021- 2031F |
6.2.5 Grenada Adalimumab Market Revenues & Volume, By Crohn's Disease, 2021- 2031F |
6.2.6 Grenada Adalimumab Market Revenues & Volume, By Ulcerative Colitis, 2021- 2031F |
6.2.7 Grenada Adalimumab Market Revenues & Volume, By Psoriatic Arthritis, 2021- 2031F |
6.2.8 Grenada Adalimumab Market Revenues & Volume, By Hidradenitis Suppurativa, 2021- 2031F |
6.2.9 Grenada Adalimumab Market Revenues & Volume, By Hidradenitis Suppurativa, 2021- 2031F |
6.3 Grenada Adalimumab Market, By Type |
6.3.1 Overview and Analysis |
6.3.2 Grenada Adalimumab Market Revenues & Volume, By Biologics, 2021- 2031F |
6.3.3 Grenada Adalimumab Market Revenues & Volume, By Biosimilars, 2021- 2031F |
6.4 Grenada Adalimumab Market, By Dosage Strength |
6.4.1 Overview and Analysis |
6.4.2 Grenada Adalimumab Market Revenues & Volume, By 40mg/0.4mlg, 2021- 2031F |
6.4.3 Grenada Adalimumab Market Revenues & Volume, By 80mg/0.8mlg, 2021- 2031F |
6.4.4 Grenada Adalimumab Market Revenues & Volume, By 20mg/0.2mlg, 2021- 2031F |
6.4.5 Grenada Adalimumab Market Revenues & Volume, By 10mg/0.1mlg, 2021- 2031F |
6.5 Grenada Adalimumab Market, By Drug Type |
6.5.1 Overview and Analysis |
6.5.2 Grenada Adalimumab Market Revenues & Volume, By Branded, 2021- 2031F |
6.5.3 Grenada Adalimumab Market Revenues & Volume, By Generics, 2021- 2031F |
6.6 Grenada Adalimumab Market, By Route of Administration |
6.6.1 Overview and Analysis |
6.6.2 Grenada Adalimumab Market Revenues & Volume, By Oral, 2021- 2031F |
6.6.3 Grenada Adalimumab Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.7 Grenada Adalimumab Market, By Dosage Form |
6.7.1 Overview and Analysis |
6.7.2 Grenada Adalimumab Market Revenues & Volume, By Injection, 2021- 2031F |
6.7.3 Grenada Adalimumab Market Revenues & Volume, By Solution, 2021- 2031F |
6.7.4 Grenada Adalimumab Market Revenues & Volume, By , 2021- 2031F |
7 Grenada Adalimumab Market Import-Export Trade Statistics |
7.1 Grenada Adalimumab Market Export to Major Countries |
7.2 Grenada Adalimumab Market Imports from Major Countries |
8 Grenada Adalimumab Market Key Performance Indicators |
9 Grenada Adalimumab Market - Opportunity Assessment |
9.1 Grenada Adalimumab Market Opportunity Assessment, By Drug class, 2021 & 2031F |
9.2 Grenada Adalimumab Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.3 Grenada Adalimumab Market Opportunity Assessment, By Type, 2021 & 2031F |
9.4 Grenada Adalimumab Market Opportunity Assessment, By Dosage Strength, 2021 & 2031F |
9.5 Grenada Adalimumab Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.6 Grenada Adalimumab Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.7 Grenada Adalimumab Market Opportunity Assessment, By Dosage Form, 2021 & 2031F |
10 Grenada Adalimumab Market - Competitive Landscape |
10.1 Grenada Adalimumab Market Revenue Share, By Companies, 2024 |
10.2 Grenada Adalimumab Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here